CLSTN3
Basic information
Region (hg38): 12:7129698-7158945
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLSTN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 80 | 82 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 80 | 3 | 3 |
Variants in CLSTN3
This is a list of pathogenic ClinVar variants found in the CLSTN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-7130691-G-T | Benign (Oct 01, 2024) | |||
12-7133120-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
12-7133132-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
12-7133137-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
12-7133629-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
12-7133639-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
12-7133640-G-A | Likely benign (Mar 01, 2022) | |||
12-7133671-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
12-7133731-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
12-7133753-C-G | not specified | Uncertain significance (Mar 10, 2025) | ||
12-7135338-A-T | not specified | Uncertain significance (Dec 03, 2021) | ||
12-7135394-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
12-7135400-G-A | not specified | Uncertain significance (Nov 24, 2024) | ||
12-7135427-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
12-7135505-C-A | not specified | Uncertain significance (Jul 12, 2022) | ||
12-7135524-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
12-7135810-T-C | Autism spectrum disorder | association (-) | ||
12-7135844-G-C | not specified | Uncertain significance (Sep 30, 2021) | ||
12-7135861-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
12-7136206-G-T | not specified | Uncertain significance (Aug 22, 2023) | ||
12-7136219-G-T | not specified | Uncertain significance (Mar 05, 2025) | ||
12-7136240-T-C | Benign (Dec 01, 2022) | |||
12-7136259-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
12-7136265-A-G | not specified | Uncertain significance (May 23, 2024) | ||
12-7136374-C-T | not specified | Uncertain significance (Dec 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLSTN3 | protein_coding | protein_coding | ENST00000266546 | 18 | 29248 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.970 | 0.0298 | 125730 | 0 | 16 | 125746 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 487 | 589 | 0.826 | 0.0000366 | 6244 |
Missense in Polyphen | 75 | 130.35 | 0.57539 | 1478 | ||
Synonymous | -0.166 | 246 | 243 | 1.01 | 0.0000155 | 1910 |
Loss of Function | 4.98 | 7 | 41.7 | 0.168 | 0.00000195 | 481 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000803 | 0.0000791 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May modulate calcium-mediated postsynaptic signals. Complex formation with APBA2 and APP, stabilizes APP metabolism and enhances APBA2-mediated suppression of beta-APP40 secretion, due to the retardation of intracellular APP maturation. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.364
- rvis_EVS
- -1.65
- rvis_percentile_EVS
- 2.76
Haploinsufficiency Scores
- pHI
- 0.359
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.621
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.293
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clstn3
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- regulation of cell growth;homophilic cell adhesion via plasma membrane adhesion molecules;synapse assembly;synaptic transmission, glutamatergic;positive regulation of synaptic transmission;synaptic transmission, GABAergic;positive regulation of synapse assembly;positive regulation of protein localization to synapse;regulation of presynapse assembly
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;cell surface;protein-containing complex;postsynaptic membrane;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic density membrane
- Molecular function
- calcium ion binding